Bionexus Gene Lab Corp (BGLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 3,245 | 3,576 | 3,092 | 3,449 | 4,126 |
| Cost of Goods | 2,738 | 2,867 | 2,625 | 2,867 | 3,743 |
| Gross Profit | 508 | 709 | 468 | 583 | 383 |
| Operating Expenses | 1,044 | 1,203 | 952 | 1,107 | 1,129 |
| Operating Income | 201 | 373 | 140 | 342 | -3 |
| Other Income | -4 | -2 | -4 | -3 | -5 |
| Pre-tax Income | 197 | 371 | 137 | 339 | -8 |
| Income Tax | 108 | 75 | 108 | N/A | 168 |
| Net Income Continuous | 89 | 295 | 28 | 339 | -176 |
| Net Income | $89 | $295 | $28 | $339 | $-176 |
| EPS Basic Total Ops | 0.36 | 0.00 | 0.00 | 0.12 | N/A |
| EPS Basic Continuous Ops | 0.06 | 0.21 | 0.02 | 0.24 | -0.21 |
| EPS Diluted Total Ops | 0.36 | 0.00 | 0.00 | 0.12 | N/A |
| EPS Diluted Continuous Ops | 0.06 | 0.21 | 0.02 | 0.24 | -0.21 |
| EBITDA(a) | $228 | $400 | $180 | $357 | $60 |